Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $112.5, ...

and adjustments to ratings and price targets. Capture valuable insights into HealthEquity's market standing by understanding these analyst evaluations alongside pertinent financial indicators.

Understanding Analyst Ratings: A Comprehensive Breakdown The standing of HealthEquity among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below ...

Raymond James analyst Gregory Peters upgraded Healthequity (HQY – Research Report) to a Buy yesterday and set a price target of $115.00. The ...

Similarly, Wells Fargo analyst Stan Berenshteyn has increased the price target for Healthequity to $125, maintaining an Overweight rating. He notes several legislative bills potentially enhancing ...

One analyst has rated the stock with a hold ... and health savings accounts. Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary ...

One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, HealthEquity has an average rating of “Moderate Buy” and an ...

Shares of HealthEquity (NASDAQ ... justifying long entry,” the analyst added with a Hold rating on the stock.

Investing.com - Healthequity Inc (NASDAQ ... a higher base for cybersecurity costs. However, the analyst maintained an Outperform rating and $126 price target on HQY.

HealthEquity, Inc. (NASDAQ ... At these levels, we err on selling but are giving this a neutral rating overall given where it is currently priced. When stocks run like this one had, we like ...

The Centers for Medicare and Medicaid Services finalized a substantial increase to Medicare Advantage benchmark payments over ...

The company’s non-GAAP earnings per share (EPS) of $0.78 also surpassed analyst projections ... maintain a generally positive outlook on HealthEquity’s prospects, as reflected in their price targets ...